Qiming Venture Partners, a leading China-based venture firm with over $10B AUM, launched its first independent US-based fund in 2017. Since our inception, we’ve focused on investing both our financial and human capital in early-stage healthcare opportunities in the United States and Europe, with unencumbered access to and synergy with the China market and broader Qiming network for market diligence, deal flow, and operational support.
Raised across three funds since 2017
M&A and IPOs
In order to leave a mark on human health, we strive to be a trusted, sought-after, driving force behind the leaders, companies and innovations that will shape the future of healthcare.